+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

OTC Drug and Dietary Supplement Market Opportunities and Strategies to 2033

  • PDF Icon

    Report

  • 324 Pages
  • September 2024
  • Region: Global
  • The Business Research Company
  • ID: 6004003
This report describes and explains the OTC drug and dietary supplement market and covers 2018-2023, termed the historic period, and 2023-2028, 2033F termed the forecast period. The report evaluates the market across each region and for the major economies within each region.

The global OTC drug and dietary supplement market reached a value of nearly $310.96 billion in 2023, having grown at a compound annual growth rate (CAGR) of 6.8% since 2018. The market is expected to grow from $310.96 billion in 2023 to $438.25 billion in 2028 at a rate of 7.1%. The market is then expected to grow at a CAGR of 7.6% from 2028 and reach $632.1 billion in 2033.

Growth in the historic period resulted from rise in pharma research and development (R&D) expenditure, rising healthcare expenditure, growing fitness industry and growing use of telemedicine services. Factors that negatively affected growth in the historic period were lack of awareness.

Going forward, increase in health consciousness, increasing demand for dietary supplements, rising government initiatives, increasing aging population worldwide and expansion of the e-commerce industry will drive the growth. Factor that could hinder the growth of the OTC drug and dietary supplement market in the future include side effects and safety concerns.

The OTC drug and dietary supplement market is segmented by category into vitamin and dietary supplements, cough and cold dosage forms, analgesics, gastrointestinal dosage forms, skin and other categories. The vitamin and dietary supplement market was the largest segment of the OTC drug and dietary supplement market segmented by category, accounting for 38.5% or $119.71 billion of the total in 2023. Going forward, the vitamin and dietary supplement segment is expected to be the fastest growing segment in the OTC drug and dietary supplement market segmented by category, at a CAGR of 8.2% during 2023-2028.

The OTC drug and dietary supplement market is segmented by dosage form into tablets, hard capsules, powders, ointments, soft capsules, liquids and other dosage forms. The tablets market was the largest segment of the OTC drug and dietary supplement market segmented by dosage form, accounting for 33.2% or $103.26 billion of the total in 2023. Going forward, the soft capsules segment is expected to be the fastest growing segment in the OTC drug and dietary supplement market segmented by dosage form, at a CAGR of 8.3% during 2023-2028.

The OTC drug and dietary supplement market is segmented by distribution channel into pharmacies, grocery stores, vitamin and health food stores and online pharmacies. The pharmacies market was the largest segment of the OTC drug and dietary supplement market segmented by distribution channel, accounting for pharmacies % or $144.13 billion of the total in 2023. Going forward, the online pharmacies segment is expected to be the fastest growing segment in the OTC drug and dietary supplement market segmented by distribution channel, at a CAGR of 8.5% during 2023-2028.

North America was the largest region in the OTC drug and dietary supplement market, accounting for 42.7% or $132.84 billion of the total in 2023. It was followed by Asia-Pacific, Western Europe and then the other regions. Going forward, the fastest-growing regions in the OTC drug and dietary supplement market will be Asia-Pacific and Africa where growth will be at CAGRs of 9.9% and 9.3% respectively. These will be followed by the Middle East and South America where the markets are expected to grow at CAGRs of 8.7% and 7.9% respectively.

The global OTC drug and dietary supplement market is fairly fragmented, with a large number of players operating in the market. The top ten competitors in the market made up 21.5% of the total market in 2023. Nestlé S.A. was the largest competitor with a 4.5% share of the market, followed by Procter & Gamble Co. with 3.4%, Haleon plc with 2.9%, Abbott Laboratories with 2.4%, Sanofi S.A. with 1.8%, Reckitt Benckiser Group plc with 1.7%, Bayer AG with 1.6%, Church & Dwight Co. Inc. with 1.2%, Nature’s Bounty Co. with 1% and Perrigo Company plc with 0.9%.

The top opportunities in the OTC drug and dietary supplement market segmented by category will arise in the vitamin and dietary supplements segment, which will gain $57.73 billion of global annual sales by 2028. The top opportunities in the OTC drug and dietary supplement market segmented by dosage form will arise in the tablets segment, which will gain $46.76 billion of global annual sales by 2028. The top opportunities in the OTC drug and dietary supplement market segmented by distribution channel will arise in the pharmacies segment, which will gain $60.26 billion of global annual sales by 2028. The OTC drug and dietary supplement market size will gain the most in the USA at $32.63 billion.

Market-trend-based strategies for the OTC drug and dietary supplement market include expansion of production capabilities in dietary supplements and OTC drugs, new over-the-counter option for opioid overdose reversal, launch of natural herb-based supplement for nursing mothers, introduction of OTC drug line for pain and allergy relief, innovation in women's health pharmaceuticals.

Player-adopted strategies in the OTC drug and dietary supplement market include focuses on focus on expanding its business expertise through new product solutions, strengthening its business operations through strategic partnerships, and strengthening its business capabilities through the launch of new products.

To take advantage of the opportunities, the analyst recommends the OTC drug and dietary supplement companies to focus on production expansion for market leadership, focus on expanding access to opioid overdose reversal solutions, focus on developing natural herb-based supplements for nursing mothers, focus on expanding otc drug lines for pain and allergy relief, focus on innovating with otc oral contraceptives, focus on vitamin and dietary supplements segment, focus on online pharmacies, focus on expanding presence in emerging markets, focus on competitive pricing strategies, embrace digital marketing channels, educate consumers through content marketing and focus on targeting aging population effectively.

Table of Contents

1 Executive Summary
1.1 OTC Drug and Dietary Supplement - Market Attractiveness and Macro economic Landscape
2 Table of Contents3 List of Tables4 List of Figures5 Report Structure
6 Market Characteristics
6.1 General Market Definition
6.2 Summary
6.3 OTC Drug and Dietary Supplement Market Definition and Segmentations
6.4 Market Segmentation by Category
6.4.1 Vitamin and Dietary Supplements
6.4.2 Cough and Cold Products
6.4.3 Analgesics
6.4.4 Gastrointestinal Products
6.4.5 Skin
6.4.6 Other Categories
6.5 Market Segmentation by Dosage Form
6.5.1 Tablets
6.5.2 Hard Capsules
6.5.3 Powders
6.5.4 Ointments
6.5.5 Soft Capsules
6.5.6 Liquids
6.5.7 Other Dosage Forms
6.6 Market Segmentation by Distribution Channel
6.6.1 Pharmacies
6.6.2 Grocery Stores
6.6.3 Vitamin and Health Food Stores
6.6.4 Online Pharmacies
7 Major Market Trends
7.1 Expansion of Production Capabilities in Dietary Supplements and OTC Drugs
7.2 New Over-the-Counter Option for Opioid Overdose Reversal
7.3 Launch of Natural Herb-Based Supplement for Nursing Mothers
7.4 Introduction of OTC Drug Line for Pain and Allergy Relief
7.5 Innovation in Women's Health Pharmaceuticals
8 OTC Drug and Dietary Supplement Market - Macro-Economic Scenario
8.1 COVID-19 Impact on the OTC Drug and Dietary Supplement Market
8.2 Impact of the War in Ukraine on the OTC Drug and Dietary Supplement Market
8.3 Impact of High Inflation on the OTC Drug and Dietary Supplement Market
9 Global Market Size and Growth
9.1 Market Size
9.2 Historic Market Growth, 2018-2023, Value ($ Million)
9.2.1 Market Drivers 2018-2023
9.2.2 Market Restraints 2018-2023
9.3 Forecast Market Growth, 2023-2028, 2033F Value ($ Million)
9.3.1 Market Drivers 2023-2028
9.3.2 Market Restraints 2023-2028
10 Global OTC Drug and Dietary Supplement Market Segmentation
10.1 Global OTC Drug and Dietary Supplement Market, Segmentation by Category, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
10.2 Global OTC Drug and Dietary Supplement Market, Segmentation by Dosage Form, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
10.3 Global OTC Drug and Dietary Supplement Market, Segmentation by Distribution Channel, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
11 OTC Drug and Dietary Supplement Market, Regional and Country Analysis
11.1 Global OTC Drug and Dietary Supplement Market, by Region, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
11.2 Global OTC Drug and Dietary Supplement Market, by Country, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
12 Asia-Pacific Market
12.1 Summary
12.1.1 Market Overview
12.1.2 Region Information
12.1.3 Market Information
12.1.4 Background Information
12.1.5 Government Initiatives
12.1.6 Regulations
12.1.7 Regulatory Bodies
12.1.8 Major Associations
12.1.9 Taxes Levied
12.1.10 Corporate Tax Structure
12.1.11 Investments
12.1.12 Major Companies
12.2 Asia-Pacific OTC drug and Dietary Supplement Market, Segmentation by Category, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
12.3 Asia-Pacific OTC drug and Dietary Supplement Market, Segmentation by Dosage Form, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
12.4 Asia-Pacific OTC drug and Dietary Supplement Market, Segmentation by Distribution Channel, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
12.5 Asia-Pacific OTC Drug and Dietary Supplement Market: Country Analysis
12.6 China Market
12.7 Summary
12.7.1 Market Overview
12.7.2 Country Information
12.7.3 Market Information
12.7.4 Background Information
12.7.5 Government Initiatives
12.7.6 Regulations
12.7.7 Regulatory Bodies
12.7.8 Major Associations
12.7.9 Taxes Levied
12.7.10 Corporate Tax Structure
12.7.11 Investments
12.7.12 Major Companies
12.8 China OTC drug and Dietary Supplement Market, Segmentation by Category, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
12.9 China OTC drug and Dietary Supplement Market, Segmentation by Dosage Form, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
12.10 China OTC drug and Dietary Supplement Market, Segmentation by Distribution Channel, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
12.11 India Market
12.12 India OTC drug and Dietary Supplement Market, Segmentation by Category, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
12.13 India OTC drug and Dietary Supplement Market, Segmentation by Dosage Form, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
12.14 India OTC drug and Dietary Supplement Market, Segmentation by Distribution Channel, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
12.15 Japan Market
12.16 Japan OTC drug and Dietary Supplement Market, Segmentation by Category, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
12.17 Japan OTC drug and Dietary Supplement Market, Segmentation by Dosage Form, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
12.18 Japan OTC drug and Dietary Supplement Market, Segmentation by Distribution Channel, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
12.19 Australia Market
12.20 Australia OTC drug and Dietary Supplement Market, Segmentation by Category, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
12.21 Australia OTC drug and Dietary Supplement Market, Segmentation by Dosage Form, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
12.22 Australia OTC drug and Dietary Supplement Market, Segmentation by Distribution Channel, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
12.23 Indonesia Market
12.24 Indonesia OTC drug and Dietary Supplement Market, Segmentation by Category, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
12.25 Indonesia OTC drug and Dietary Supplement Market, Segmentation by Dosage Form, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
12.26 Indonesia OTC drug and Dietary Supplement Market, Segmentation by Distribution Channel, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
12.27 South Korea Market
12.28 South Korea OTC drug and Dietary Supplement Market, Segmentation by Category, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
12.29 South Korea OTC drug and Dietary Supplement Market, Segmentation by Dosage Form, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
12.30 South Korea OTC drug and Dietary Supplement Market, Segmentation by Distribution Channel, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
13 Western Europe Market
13.1 Summary
13.1.1 Market Overview
13.1.2 Region Information
13.1.3 Market Information
13.1.4 Background Information
13.1.5 Government Initiatives
13.1.6 Regulations
13.1.7 Regulatory Bodies
13.1.8 Major Associations
13.1.9 Taxes Levied
13.1.10 Corporate tax structure
13.1.11 Investments
13.1.12 Major Companies
13.2 Western Europe OTC Drug and Dietary Supplement Market, Segmentation by Category, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
13.3 Western Europe OTC Drug and Dietary Supplement Market, Segmentation by Dosage Form, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
13.4 Western Europe OTC Drug and Dietary Supplement Market, Segmentation by Distribution Channel, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
13.5 Western Europe OTC Drug and Dietary Supplement Market: Country Analysis
13.6 UK Market
13.7 UK OTC Drug and Dietary Supplement Market, Segmentation by Category, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
13.8 UK OTC Drug and Dietary Supplement Market, Segmentation by Dosage Form, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
13.9 UK OTC Drug and Dietary Supplement Market, Segmentation by Distribution Channel, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
13.10 Germany Market
13.11 Germany OTC Drug and Dietary Supplement Market, Segmentation by Category, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
13.12 Germany OTC Drug and Dietary Supplement Market, Segmentation by Dosage Form, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
13.13 Germany OTC Drug and Dietary Supplement Market, Segmentation by Distribution Channel, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
13.14 France Market
13.15 France OTC Drug and Dietary Supplement Market, Segmentation by Category, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
13.16 France OTC Drug and Dietary Supplement Market, Segmentation by Dosage Form, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
13.17 France OTC Drug and Dietary Supplement Market, Segmentation by Distribution Channel, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
13.18 Italy Market
13.19 Italy OTC Drug and Dietary Supplement Market, Segmentation by Category, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
13.20 Italy OTC Drug and Dietary Supplement Market, Segmentation by Dosage Form, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
13.21 Italy OTC Drug and Dietary Supplement Market, Segmentation by Distribution Channel, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
13.22 Spain Market
13.23 Spain OTC Drug and Dietary Supplement Market, Segmentation by Category, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
13.24 Spain OTC Drug and Dietary Supplement Market, Segmentation by Dosage Form, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
13.25 Spain OTC Drug and Dietary Supplement Market, Segmentation by Distribution Channel, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
14 Eastern Europe Market
14.1 Summary
14.1.1 Market Overview
14.1.2 Region Information
14.1.3 Market Information
14.1.4 Background Information
14.1.5 Government Initiatives
14.1.6 Regulations
14.1.7 Regulatory Bodies
14.1.8 Major Associations
14.1.9 Taxes Levied
14.1.10 Corporate Tax Structure
14.1.11 Investments
14.1.12 Major Companies
14.2 Eastern Europe OTC drug and Dietary Supplement Market, Segmentation by Category, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
14.3 Eastern Europe OTC drug and Dietary Supplement Market, Segmentation by Dosage Form, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
14.4 Eastern Europe OTC drug and Dietary Supplement Market, Segmentation by Distribution Channel, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
14.5 Eastern Europe OTC drug and Dietary Supplement Market: Country Analysis
14.6 Russia Market
14.7 Russia OTC drug and Dietary Supplement Market, Segmentation by Category, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
14.8 Russia OTC drug and Dietary Supplement Market, Segmentation by Dosage Form, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
14.9 Russia OTC drug and Dietary Supplement Market, Segmentation by Distribution Channel, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
15 North America Market
15.1 Summary
15.1.1 Market Overview
15.1.2 Region Information
15.1.3 Market Information
15.1.4 Background Information
15.1.5 Government Initiatives
15.1.6 Regulations
15.1.7 Regulatory Bodies
15.1.8 Major Associations
15.1.9 Taxes Levied
15.1.10 Corporate Tax Structure
15.1.11 Investments
15.1.12 Major Companies
15.2 North America OTC Drug and Dietary Supplement Market, Segmentation by Category, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
15.3 North America OTC Drug and Dietary Supplement Market, Segmentation by Dosage Form, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
15.4 North America OTC Drug and Dietary Supplement Market, Segmentation by Distribution Channel, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
15.5 North America OTC Drug and Dietary Supplement Market: Country Analysis
15.6 USA Market
15.7 Summary
15.7.1 Market Overview
15.7.2 Country Information
15.7.3 Market Information
15.7.4 Background Information
15.7.5 Government Initiatives
15.7.6 Regulations
15.7.7 Regulatory Bodies
15.7.8 Major Associations
15.7.9 Taxes Levied
15.7.10 Corporate Tax Structure
15.7.11 Investments
15.7.12 Major Companies
15.8 USA OTC Drug and Dietary Supplement Market, Segmentation by Category, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
15.9 USA OTC Drug and Dietary Supplement Market, Segmentation by Dosage Form, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
15.10 USA OTC Drug and Dietary Supplement Market, Segmentation by Distribution Channel, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
15.11 Canada Market
15.12 Canada OTC Drug and Dietary Supplement Market, Segmentation by Category, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
15.13 Canada OTC Drug and Dietary Supplement Market, Segmentation by Dosage Form, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
15.14 Canada OTC Drug and Dietary Supplement Market, Segmentation by Distribution Channel, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
16 South America Market
16.1 Summary
16.1.1 Market Overview
16.1.2 Region Information
16.1.3 Market Information
16.1.4 Background Information
16.1.5 Government Initiatives
16.1.6 Regulations
16.1.7 Regulatory Bodies
16.1.8 Major Associations
16.1.9 Taxes Levied
16.1.10 Corporate Tax Structure
16.1.11 Investments
16.1.12 Major Companies
16.2 South America OTC Drug and Dietary Supplement Market, Segmentation by Category, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
16.3 South America OTC Drug and Dietary Supplement Market, Segmentation by Dosage Form, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
16.4 South America OTC Drug and Dietary Supplement Market, Segmentation by Distribution Channel, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
16.5 South America OTC Drug and Dietary Supplement Market: Country Analysis
16.6 Brazil Market
16.7 Brazil OTC Drug and Dietary Supplement Market, Segmentation by Category, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
16.8 Brazil OTC Drug and Dietary Supplement Market, Segmentation by Dosage Form, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
16.9 Brazil OTC Drug and Dietary Supplement Market, Segmentation by Distribution Channel, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
17 Middle East Market
17.1 Summary
17.1.1 Market Overview
17.1.2 Region Information
17.1.3 Market Information
17.1.4 Background Information
17.1.5 Government Initiatives
17.1.6 Regulations
17.1.7 Regulatory Bodies
17.1.8 Major Associations
17.1.9 Taxes Levied
17.1.10 Corporate Tax Structure
17.1.11 Investments
17.1.12 Major Companies
17.2 Middle East OTC drug and Dietary Supplement Market, Segmentation by Category, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
17.3 Middle East OTC drug and Dietary Supplement Market, Segmentation by Dosage Form, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
17.4 Middle East OTC drug and Dietary Supplement Market, Segmentation by Distribution Channel, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
18 Africa Market
18.1 Summary
18.1.1 Market Overview
18.1.2 Region Information
18.1.3 Market Information
18.1.4 Background Information
18.1.5 Government Initiatives
18.1.6 Regulations
18.1.7 Regulatory Bodies
18.1.8 Major Associations
18.1.9 Taxes Levied
18.1.10 Corporate Tax Structure
18.1.11 Investments
18.1.12 Major Companies
18.2 Africa OTC drug and Dietary Supplement Market, Segmentation by Category, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
18.3 Africa OTC drug and Dietary Supplement Market, Segmentation by Dosage Form, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
18.4 Africa OTC drug and Dietary Supplement Market, Segmentation by Distribution Channel, Historic and Forecast, 2018-2023, 2028F, 2033F, Value ($ Million)
19 Competitive Landscape and Company Profiles
19.1 Company Profiles
19.2 Nestle S.a.
19.2.1 Company Overview
19.2.2 Products and Services
19.2.3 Business Strategy
19.2.4 Financial Overview
19.3 The Procter & Gamble Company
19.3.1 Company Overview
19.3.2 Products and Services
19.3.3 Financial Overview
19.4 Haleon plc
19.4.1 Company Overview
19.4.2 Products and Services
19.4.3 Business Strategy
19.4.4 Financial Overview
19.5 Abbott Laboratories
19.5.1 Company Overview
19.5.2 Products and Services
19.5.3 Business Strategy
19.5.4 Financial Overview
19.6 Sanofi S.a
19.6.1 Company Overview
19.6.2 Products and Services
19.6.3 Business Strategy
19.6.4 Financial Overview
20 Other Major and Innovative Companies
20.1 Reckitt Benckiser Group plc
20.1.1 Company Overview
20.1.2 Products and Services
20.2 Bayer AG
20.2.1 Company Overview
20.2.2 Products and Services
20.3 Church & Dwight Co. Inc
20.3.1 Company Overview
20.3.2 Products and Services
20.4 Nature's Bounty Co
20.4.1 Company Overview
20.4.2 Products and Services
20.5 Perrigo Company plc
20.5.1 Company Overview
20.5.2 Products and Services
20.6 GNC Holdings Inc.
20.6.1 Company Overview
20.6.2 Products and Services
20.7 Sun Pharmaceutical Industries Ltd
20.7.1 Company Overview
20.7.2 Products and Services
20.8 Novartis AG
20.8.1 Company Overview
20.8.2 Products and Services
20.9 Pfizer Inc
20.9.1 Company Overview
20.9.2 Products and Services
20.10 Merck & Co. Inc
20.10.1 Company Overview
20.10.2 Products and Services
20.11 Pharmavite LLC
20.11.1 Company Overview
20.11.2 Products and Services
20.12 Hain Celestial Group Inc
20.12.1 Company Overview
20.12.2 Products and Services
20.13 Blackmores Limited
20.13.1 Company Overview
20.13.2 Products and Services
20.14 Cipla Inc
20.14.1 Company Overview
20.14.2 Products and Services
20.15 Amway
20.15.1 Company Overview
20.15.2 Products and Services
21 Competitive Benchmarking22 Competitive Dashboard
23 Key Mergers and Acquisitions
23.1 Dr. Reddy's Laboratories Acquired MenoLabs
23.2 Dexcel Pharma Acquired Teva Pharmaceutical Industries Ltd
23.3 Cipla Limited Acquired Actor Pharma
23.4 SGS S.a. Acquired Nutrasource Pharmaceutical and Nutraceutical Services Inc.
23.5 The Kirin Holdings Company Limited Acquired Blackmores Limited
23.6 Balchem Corporation Acquired Bergstrom Nutrition
23.7 Glenmark Pharmaceuticals Ltd Acquired Wockhardt Ltd
23.8 Acino Acquired Aspen Pharmacare Holdings Limited
23.9 Douglas Acquired Disapo
23.10 Merieux NutriSciences Acquired Dyad Labs
23.11 Laboratorios Rubió Acquired Fisiopharma S.r.l.
23.12 Fidia Farmaceutici Acquired Sanofi
24 Opportunities and Strategies
24.1 Global OTC Drug and Dietary Supplement Market in 2028 - Countries Offering Most New Opportunities
24.2 Global OTC Drug and Dietary Supplement Market in 2028 - Segments Offering Most New Opportunities
24.3 Global OTC Drug and Dietary Supplement Market in 2028 - Growth Strategies
24.3.1 Market Trend-based Strategies
24.3.2 Competitor Strategies
25 OTC Drug and Dietary Supplement Market, Conclusions and Recommendations
25.1 Conclusions
25.2 Recommendations
25.2.1 Product
25.2.2 Place
25.2.3 Price
25.2.4 Promotion
25.2.5 People
26 Appendix
26.1 Geographies Covered
26.2 Market Data Sources
26.3 Research Methodology
26.4 Currencies
26.5 About the Analyst
26.6 Copyright and Disclaimer

Executive Summary

OTC Drug And Dietary Supplement Global Market Opportunities And Strategies To 2033 provides the strategists; marketers and senior management with the critical information they need to assess the global OTC drug and dietary supplement market as it emerges from the COVID-19 shut down.

Reasons to Purchase:

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Description

Where is the largest and fastest-growing market for OTC drug and dietary supplement? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The OTC drug and dietary supplement market global report answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s history and forecasts market growth by geography. It places the market within the context of the wider OTC drug and dietary supplement market; and compares it with other markets.

The report covers the following chapters

  • Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by category, by dosage form and by distribution channel.
  • Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
  • Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the OTC drug and dietary supplement market.
  • Global Market Size And Growth- Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional And Country Analysis- Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
  • Market Segmentation- Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by category, by dosage form and by distribution channel in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
  • Regional Market Size and Growth- Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Other Major And Innovative Companies- Details on the company profiles of other major and innovative companies in the market.
  • Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
  • Competitive Dashboard- Briefs on competitive dashboard of major players.
  • Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
  • Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
  • Conclusions And Recommendations- This section includes recommendations for OTC drugs and dietary supplement providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
  • Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

1) By Category: Vitamin And Dietary Supplements; Cough And Cold Dosage Forms; Analgesics; Gastrointestinal Dosage Forms; Skin; Other Categories
2) By Dosage Form: Tablets; Hard Capsules; Powders; Ointments; Soft Capsules; Liquids; Other Dosage Forms
3) By Distribution Channel: Pharmacies; Grocery Stores; Vitamin And Health Food Stores; Online Pharmacies

Key Companies Mentioned: Nestlé S.A.; Procter & Gamble Co.; Haleon plc; Abbott Laboratories; Sanofi S.A.

Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; Italy; Spain; UK; Russia

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; OTC drug and dietary supplement indicators comparison.

Data Segmentation: Country and regional historic and forecast data; market share of competitors; market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Companies Mentioned

  • Nestlé S.A.
  • Procter & Gamble Co.
  • Haleon plc
  • Abbott Laboratories
  • Sanofi S.A.
  • Reckitt Benckiser Group plc
  • Bayer AG
  • Church & Dwight Co. Inc.
  • Nature’s Bounty Co.
  • Perrigo Company plc
  • PT Darya-Varia Laboratoria Tbk
  • Citra Nusa Insan Cemerlang PT
  • Sido Muncul
  • Tempo Scan Pacific Tbk PT
  • Ajinomoto Co. Inc
  • Otsuka Pharmaceutical Co., Ltd.
  • KOBAYASHI Pharmaceutical Co.,Ltd.
  • Blackmores Limited
  • Fonterra Co-operative Group Limited
  • Dong-A Pharmaceutical Co., Ltd.
  • Kolmar Korea
  • Il Yang Pharmaceutical
  • Pulmuone Health & Living Co Ltd
  • Emcure Pharmaceuticals Limited
  • GSK plc
  • BASF SE
  • Glanbia plc
  • Perrigo Company plc
  • ARKOPHARMA Laboratories Company Limited
  • Laboratorios Rubió S.A.
  • Fisiopharma S.r.l.
  • Juvamine
  • Solgar Science
  • Oenobiol
  • Naturactive
  • Puressentiel
  • Danone S.A.
  • AstraZeneca plc
  • LEO Pharma A/S
  • Novartis AG
  • Omega Pharma Srl
  • Farmaderbe
  • Sopharma Group
  • Orifarm Group A/S
  • Polpharma SA
  • Zentiva
  • Stada Arzneimittel AG
  • Krka, d. d.
  • Aflofarm
  • Herbapol Lublin
  • Ropharma
  • Dacia Plant
  • Hofigal
  • Evalar
  • JSC Pharmstandard
  • Jamieson Wellness Inc.
  • Natural Factors
  • Organika Health Products Inc.
  • Genomma Lab Internacional
  • Laboratorios Liomont
  • Medix
  • Pfizer Inc.
  • Johnson & Johnson
  • GSK Consumer Healthcare
  • Church & Dwight Co., Inc.
  • Elea Phoenix
  • Laboratorio Elea
  • Hypera Pharma
  • Laboratorios La Santé
  • Laboratorios Saval
  • Laboratorio Chile
  • Laboratorio Knop
  • Laboratorio Franco Colombiano Lafrancol
  • Corporación Infarmasa
  • Medifarma
  • Citrosuco
  • Darou Pakhsh Pharmaceutical Manufacturing Co.
  • Teva Pharmaceutical Industries Ltd.
  • Tabuk Pharmaceuticals Manufacturing Company
  • Abdi Ibrahim Pharmaceuticals
  • Caspian Tamin Pharmaceutical Company
  • Exir Pharmaceutical Company
  • Saudi Pharmaceutical Industries & Medical Appliances Corporation (SPIMACO)
  • Jamjoom Pharmaceuticals
  • Zahravi Pharmaceutical Company
  • Alhavi Pharmaceutical Company
  • Dexxon Pharmaceutical Active Ingredients
  • Aspen Pharmacare Holdings Limited
  • Actor Pharma
  • Sandoz
  • IBN SINA Pharmaceutical
  • Egyptian International Pharmaceutical Industries Company (EIPICO)
  • EVA Pharma
  • Pharco Pharmaceuticals
  • Amoun Pharmaceutical Company S.A.E.
  • Adcock Ingram
  • Solal Technologies

Methodology

Loading
LOADING...

Table Information